Generating Evidence that RABEP2 is a Novel GSK3 Substrate that Represents a Single Therapeutic Target to Reduce Both Hyperglycemia and Microvascular Disease in Diabetes (joint with Glasgow Uni)
- Kang, Li (Investigator)
- Khan, Faisel (Investigator)
- Murdoch, Colin (Investigator)
- Sutherland, Calum (Investigator)